Tecentriq 1200 mg/20 ml
Tecentriq 1200 mg/20 ml is a medicine authorised by Swissmedic under authorisation number 66152. The authorisation holder is Roche Pharma (Schweiz) AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 23 May 2017 and the authorisation is valid without a time limit. ATC code L01FF05 places the medicine in the group Antineoplastic agents.
| Authorisation number | 66152 |
|---|---|
| Name | Tecentriq 1200 mg/20 ml |
| Full name | Tecentriq 1200 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Roche Pharma (Schweiz) AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FF05 |
| First authorisation | 23 May 2017 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Tecentriq 1200 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 23 May 2017 |
| 2 | Tecentriq 840 mg/14 ml, Konzentrat zur Herstellung einer Infusionslösung | A | 21 May 2019 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01FF05 | 07.16.1. | A |
| 2 | 1 | Durchstechflasche(n) | L01FF05 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Tecentriq 1200 mg/20 ml authorised in Switzerland?
Yes. Tecentriq 1200 mg/20 ml is authorised by Swissmedic under authorisation number 66152, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Tecentriq 1200 mg/20 ml have?
Tecentriq 1200 mg/20 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Tecentriq 1200 mg/20 ml?
The authorisation holder is Roche Pharma (Schweiz) AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.